In this context, non-steroidal anti-inflammatory drugs, which are COX-2 inhibitors, could at the same time lower PGE2 levels and IDO1 expression, leading to Treg cell downmodulation as seen in the reversion of tumor immune evasion in cancer models53,90. The gene discussed is PTGS2; the disease is cancer.